Market Research Logo

Clinical Diagnostics Market in APAC - Market Analysis 2015-2019

Clinical Diagnostics Market in APAC - Market Analysis 2015-2019

About clinical diagnostics

Clinical diagnostics or in-vitro diagnostics is a method to perform diagnostics tests by using instruments, assay reagents, and systems to diagnose a disease or medical condition in a laboratory. Early and accurate diagnosis of life-threatening diseases such as cancer, cardiovascular disease, and influenza will boost the sales of clinical diagnostics products. Factor such as a rapid increase in the number of people with diabetes in developing countries such as in India will increase the sales of diagnostics as there are 50 million diabetes patients. Diabetes can increase the risk of active TB, and this infection can worsen the blood glucose level. To handle this types of medical cases, rapid molecular TB diagnosis is done.

Technavio's analysts forecast the clinical diagnostics market in APAC to grow at a CAGR of 12.90% over the period 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the clinical diagnostics market in APAC for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of diagnostic kits, instruments, and reagents:

  • POC
  • Tissue diagnostic
  • Clinical microbiology
  • Immunodiagnostics
  • Molecular diagnostic
  • Hematology
Technavio's report, Clinical Diagnostics Market in APAC 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC; it also covers the landscape of the clinical diagnostic market in APAC and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.Key vendors
  • Abbott
  • Beckman Coulter Diagnostics
  • Biomerieux
  • Qiagen
  • Roche
Other prominent vendors
  • Amgenix International
  • BD
  • Cepheid
  • DiagCor
  • Hologic
  • J. Mitra
  • Landwind Medical
  • Life Technologies
  • Mindray
  • Randox Laboratories
  • Snibe Diagnostics
  • Span Diagnostics
  • Sysmex
  • Tosoh
  • Trivitron Healthcare
  • URIT
Key market driver
  • Early and accurate diagnosis of life-threatening diseases
  • For a full, detailed list, view our report
Key market challenge
  • Lack of infrastructure and trained professionals
  • For a full, detailed list, view our report
Key market trend
  • Privatization and healthcare coverage
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Clinical Diagnostics Market in APAC 2015-2019

Technavio recognizes the following companies as the key players in the Clinical Diagnostics Market in APAC: Abbott, Biomerieux, Beckman Coulter Diagnostics, Roche and Qiagen

Other Prominent Vendors in the market are: Amgenix International, BD, Cepheid, DiagCor, Hologic, Life Technologies, J. Mitra & Co Pvt. Ltd, Landwind Medical, Mindray, Randox Laboratories, Span Diagnostics, Snibe Diagnostics, Sysmex, Trivitron Healthcare, Tosoh Corporation, and URIT.

Commenting on the report, an analyst from Technavio’s team said: “Genetic changes occur in all kinds of microorganisms, which make them resistant to antibiotics. Such microbes delay disease diagnosis and hinder treatment procedures. WHO reported that the number of multi-drug resistant tuberculosis cases is increasing worldwide, particularly in China and India. These countries reported a total of 220,000 cases of antibiotic-resistant infections in 2013. Early disease diagnosis helps control the rising prevalence of infectious diseases and associated costs. This has increased the demand for clinical diagnostics kits and equipment to detect multi-drug resistant or antibiotic-resistant microorganisms during diagnosis.”

According to the report, the market in APAC is developed, encouraging manufacturers to employ various strategies to increase their market shares. These strategies include new technology-based products, product line extension, and modification and upgrading of clinical diagnostic systems. Vendors also undergo M&A and invest in advertising to increase product sales and gain profits. For instance, in June 2014, Roche Diagnostics, the leading vendor in China, acquired Genia Technologies to strengthen the former's NGS product pipeline.

Further, the report states that traditional clinical diagnostic methods are time consuming, delaying results and treatment. For instance, conventional blood culturing methods can provide inaccurate results and show reduced sensitivity. Conventional PCR technology is cost-effective but time consuming. The technology lacks automation as opposed to real-time PCR, and thus takes time to provide results and delays treatment.

Companies Mentioned

Abbott, Biomerieux, Beckman Coulter Diagnostics, Roche, Qiagen, Amgenix International, BD, Cepheid, DiagCor, Hologic, Life Technologies, J. Mitra & Co Pvt. Ltd, Landwind Medical, Mindray, Randox Laboratories, Span Diagnostics, Snibe Diagnostics, Sysmex, Trivitron Healthcare, Tosoh Corporation, URIT.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Clinical diagnostics market in APAC 2014-2019 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Impact of regulatory services
    • Impact of regulatory services on clinical diagnostic devices
      • Table Regulatory bodies and their policies for clinical diagnostic devices in APAC
  • Clinical diagnostics: Product pipeline
    • Table Clinical diagnostics pipeline of various companies
  • Market segmentation by product
    • Table Segmentation of clinical diagnostics market in APAC by product
    • Table Segmentation of clinical diagnostics market in APAC by product 2014
    • Immunodiagnostics market in APAC
      • Table Immunodiagnostics market in APAC 2014-2019 ($ billions)
    • POC diagnostics market in APAC
      • Table POC diagnostics market in APAC 2014-2019 ($ billions)
    • Molecular diagnostics market in APAC
      • Table Molecular diagnostics market in APAC 2014-2019 ($ millions)
    • Hematology devices market in APAC
      • Table Hematology devices market in APAC 2014-2019 ($ billions)
    • Tissue diagnostics market in APAC
      • Table Tissue diagnostics market in APAC 2014-2019 ($ millions)
    • Clinical microbiology systems market in APAC
      • Table Clinical microbiology systems market in APAC 2014-2019 ($ millions)
  • Market drivers
    • Early and accurate diagnosis of life-threatening diseases
    • Market expansion
    • POC home diagnostics
    • Government funding
    • Domestic manufacturing of devices in China
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Lack of infrastructure and skilled professionals
    • Issues with intellectual property rights
    • Availability of counterfeit IVD products
    • Inaccuracy of conventional diagnostics
    • Pricing policies and unfavorable reimbursement policies in China
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Privatization and healthcare coverage
    • Emergence of antibiotic-resistant pathogens
    • Personalized medicines
    • Next-generation technology and DNA microarrays
    • Local distributors as intermediaries
  • Vendor landscape
    • Competitive scenario
    • Market share analysis 2014
      • Table Abbott Diagnostics: Key takeaways
      • Table Beckman Coulter: Key takeaways
      • Table bioMérieux: Key takeaways
      • Table Qiagen: Key takeaways
      • Table Roche Diagnostics: Key takeaways
    • Other prominent vendors
  • Key vendor analysis
    • Abbott Diagnostics
    • bioMérieux
    • Beckman Coulter
    • Qiagen
    • Roche Diagnostics
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report